EUR 1.29
(2.7%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 78.13 Million EUR | -22.36% |
2022 | 100.64 Million EUR | 1.3% |
2021 | 99.35 Million EUR | 34.47% |
2020 | 73.88 Million EUR | 472.32% |
2019 | 12.9 Million EUR | 57.27% |
2018 | 8.2 Million EUR | 935.23% |
2017 | 792.93 Thousand EUR | -6.13% |
2016 | 844.72 Thousand EUR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 82.32 Million EUR | 13.82% |
2024 Q1 | 72.32 Million EUR | -7.43% |
2023 Q2 | 88.37 Million EUR | -8.74% |
2023 FY | 78.13 Million EUR | -22.36% |
2023 Q4 | 78.13 Million EUR | -5.74% |
2023 Q3 | 82.89 Million EUR | -6.21% |
2023 Q1 | 96.84 Million EUR | -3.77% |
2022 Q1 | 117.09 Million EUR | 17.86% |
2022 Q4 | 100.64 Million EUR | -4.75% |
2022 Q3 | 105.65 Million EUR | -4.98% |
2022 Q2 | 111.19 Million EUR | -5.04% |
2022 FY | 100.64 Million EUR | 1.3% |
2021 FY | 99.35 Million EUR | 34.47% |
2021 Q4 | 99.35 Million EUR | -2.78% |
2021 Q3 | 102.19 Million EUR | -0.95% |
2021 Q2 | 103.17 Million EUR | -4.0% |
2021 Q1 | 107.47 Million EUR | 45.46% |
2020 FY | 73.88 Million EUR | 472.32% |
2020 Q2 | 83.48 Million EUR | 569.14% |
2020 Q4 | 73.88 Million EUR | -3.81% |
2020 Q3 | 76.81 Million EUR | -8.0% |
2020 Q1 | 12.47 Million EUR | -3.35% |
2019 Q4 | 12.9 Million EUR | 0.0% |
2019 Q1 | - EUR | 0.0% |
2019 FY | 12.9 Million EUR | 57.27% |
2018 FY | 8.2 Million EUR | 935.23% |
2017 FY | 792.93 Thousand EUR | -6.13% |
2016 FY | 844.72 Thousand EUR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Biohit Oyj | 12.9 Million EUR | -505.695% |
Herantis Pharma Oyj | 6.74 Million EUR | -1058.299% |